 I. To determine the toxicity profile of the SVN53-67M57-KLH peptide SVN53-67M57-KLH peptide vaccine in Montanide ISA 51 incomplete Freunds adjuvant plus GM-CSF sargramostim vaccine, given before or after the start of lenalidomide maintenance in patients with multiple myeloma. 